Robert F Apple - Net Worth and Insider Trading
Robert F Apple Net Worth
The estimated net worth of Robert F Apple is at least $12 Million dollars as of 2024-04-24. Robert F Apple is the President & CEO of Antares Pharma Inc and owns about 2,204,760 shares of Antares Pharma Inc (ATRS) stock worth over $12 Million. Details can be seen in Robert F Apple's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert F Apple has not made any transactions after 2021-02-18 and currently still holds the listed stock(s).
Transaction Summary of Robert F Apple
Robert F Apple Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert F Apple owns 1 companies in total, including Antares Pharma Inc (ATRS) .
Click here to see the complete history of Robert F Apple’s form 4 insider trades.
Insider Ownership Summary of Robert F Apple
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATRS | Antares Pharma Inc | 2021-02-18 | director & President & CEO |
Robert F Apple Latest Holdings Summary
Robert F Apple currently owns a total of 1 stock. Robert F Apple owns 2,204,760 shares of Antares Pharma Inc (ATRS) as of February 18, 2021, with a value of $12 Million.
Latest Holdings of Robert F Apple
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ATRS | Antares Pharma Inc | 2021-02-18 | 2,204,760 | 5.59 | 12,324,608 |
Holding Weightings of Robert F Apple
Robert F Apple Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert F Apple has made a total of 3 transactions in Antares Pharma Inc (ATRS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Antares Pharma Inc is the sale of 497,479 shares on February 18, 2021, which brought Robert F Apple around $2 Million.
Insider Trading History of Robert F Apple
- 1
Robert F Apple Trading Performance
GuruFocus tracks the stock performance after each of Robert F Apple's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert F Apple is 38.36%. GuruFocus also compares Robert F Apple's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert F Apple within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert F Apple's insider trading performs compared to the benchmark.
Performance of Robert F Apple
Average Return
283.56%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 21.92 | 38.36 | 95.89 | 283.56 | 82.75 | 68.46 |
Relative Return to S&P 500(%) | 19.74 | 37.3 | 91.52 | 267.52 | 66.83 | 57.07 |
Robert F Apple Ownership Network
Ownership Network List of Robert F Apple
Ownership Network Relation of Robert F Apple
Robert F Apple Owned Company Details
What does Antares Pharma Inc do?
Who are the key executives at Antares Pharma Inc?
Robert F Apple is the director & President & CEO of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter J Graham , See Remarks Peter C Richardson , and Executive Vice President & CFO Fred M Powell .
Antares Pharma Inc (ATRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antares Pharma Inc Insider Transactions
Robert F Apple Mailing Address
Above is the net worth, insider trading, and ownership report for Robert F Apple. You might contact Robert F Apple via mailing address: C/o Inkline Pharmaceutical Co Inc Sentry Park East 1720 Walton Road Blue Bell Pa 19422.